PPT-Blood Component Therapy Dr Nishant Verma

Department of Pediatrics KGMU Lucknow Historical Time Line 17 th century 1 st recorded transfusion from man to animal 1901 Karl Landsteiners discovery of ABO grouping laid foundation for scientific transfusion practices. Super Component of . Blood Sugar . Monitor. 1. Term . Project. Description: . Monitoring patients blood sugar, based on different . knowledge bases, . to generate a customized alert & alert . messages.. Cu rriculum Vitae 1 Dr. Nishant Shah (Ph.D) Postal Address: 12, Volgerstrasse, Lueneburg 21335, Niedersachsen, Germany. Phone : +49 - 176 - 841 - 660 - 87 email: - india.org Current Profile:  Dr Nishant Verma. Department of Pediatrics,. KGMU, Lucknow. Historical Time Line. 17. th. century- 1. st. recorded transfusion (from man to animal). 1901- Karl Landsteiner’s discovery of ABO grouping laid foundation for scientific transfusion practices. By: Oli iorio, Victoria barakett, olivia dicaprio and maria kambitakis. the circulatory system. Contains:. — Plasma (liquid component). — RBC (solid component). — WBC (solid component). — Platelets (solid component). Minh-Ha Tran. Learning Objectives. After participating in this activity, participants will be able to:. Utilize newfound knowledge of transfusion risk to provide informed consent for blood transfusion. nt TransfusLons - TaJaOoJ SarLwanJ fro]en na pOasma NaJOaOaman nJ mJa pamumuonJ saOLN. AnJ sarLwanJ fro]en na pOasma a\ pOama na fro]en at LnLmbaN aJad matapos Lto naNuKa muOa sa donor nJ duJo. AnJ sa 1
 \n

\r
 

 \n\n\r\r\n\n \r\n\r\r
  !" # #"$ % !%" 1C-January 2021An Attributionof Value Frameworkfor Combination Therapies Report by the Value Attribution Working GroupJanuary20212C-ANPROM/UK/PIP/0001January 2021AuthorsAndrew H Briggs12Alexis Doyle2J Department of Pediatrics. King George’s Medical University, . Lucknow. Normal Growth . and. Development. Definitions . Growth. Increase in size or mass. Wt, Ht, HC. Development. Maturation of functions. Triad of thrombocytopenia, micro-. angiopathic. hemolytic anemia and acute renal failure. The most common cause of HUS is systemic uptake of Shiga-like toxin (. Stx. or . verotoxin. ) from . Stx. -producing Escherichia coli (STEC) O157:H7, ( . Dr. M. . Shoaib. D/o Ilaj-bit-Tadbeer. Faculty of Unani Medicine. Aligarh Muslim University. Aligarh-202002. Leech therapy. Ta’aleeq. . Irsale. . Alaq. . Bdellotherapy. Hirudotherapy. Concept of disease in Unani medicine. http://www.cs.uh.edu/~rmverma. Research Interests and Projects. Rewriting – LRR, Basic Decision Problems, Applications. Data/Text Mining – Summarization, Q/A, Data Mining Course. BP lowering Drug Efficacy - . Monotherapy. Law MR, et al. BMJ 2003. Fall in BP (mmHg). Standard dose. Twice standard dose. Systolic BP. . Thiazides. 8.8. 10.3. . β. blockers. 9.2. 11.1. ACE inhibitors. Differences from Systemic Circulation . Low peripheral Resistance . Low pressure . Systolic20-25 mm Hg, Diastolic 6 -12 mm Hg & Mean 15mm Hg. Pulmonary Arterioles Thin walled, large lumen . Pulmonary Capillaries shorter and wider and blood flow is pulsatile .